2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells

Journal of Biochemistry

Volumn 135, Issue 4, 2004, Pages 517-524

  Kishimoto, Seishi ^a   Kobayashi, Yuriko ^a   Oka, Saori ^a   Gokoh, Maiko ^a   Waku, Keizo ^a   Sugiura, Takayuki ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

2 arachidonoylglycerol; Anandamide; Cannabinoid; CB2 receptor; Chemokine

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; ARACHIDONIC ACID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CHEMOKINE; INTERLEUKIN 8; LIGAND; LIPOPOLYSACCHARIDE; MACROPHAGE CHEMOATTRACTANT PROTEIN 1; MACROPHAGE CHEMOTACTIC FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; MACROPHAGE; REGULATORY MECHANISM;

ARACHIDONIC ACID; ARACHIDONIC ACIDS; BLOTTING, NORTHERN; BORNANES; CALCITRIOL; CELL DIFFERENTIATION; CHEMOKINE CCL2; CHEMOKINES; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GLYCERIDES; HL-60 CELLS; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RECEPTOR, CANNABINOID, CB2; RNA, MESSENGER; TIME FACTORS;

EID: 2442706289     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/jb/mvh063     Document Type: Article

References (46)

1. Dewey, W.L. (1986) Cannabinoid pharmacology. Pharmacol. Rev. 38, 151-178
2. Devane, W.A., Dysarz III, F.A., Johnson, M.R., Melvin, L.S., and Howlett, A.C. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34, 605-613
3. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., and Bonner, T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564
4. Pertwee, R.G. and Ross, R.A. (2002) Cannabinoid receptors and their ligands. Prostaglandins Leukot. Essent. Fatty Acids 66, 101-121
5. Munro, S., Thomas, K.L., and Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65
6. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949
7. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., and Waku, K. (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89-97
8. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R., Compton, D.R., Pertwee, R.G., Griffin, G., Bayewitch, M., Barg, J., and Vogel, Z. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90
9. 2+ in neuroblastoma x glioma hybrid NG108-15 cells. Biochem. Biophys. Res. Commun. 229, 58-64
10. 2+ transient in NG108-15 cells. J. Biochem. 122, 890-895
11. Sugiura, T., Kodaka, T., Nakane, S., Miyashita, T., Kondo, S., Suhara, Y., Takayama, H., Waku, K., Seki, C., Baba, N., and Ishima, Y. (1999) Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J. Biol. Chem. 274, 2794-2801
12. Sugiura, T., Kondo, S., Kishimoto, S., Miyashita, T., Nakane, S., Kodaka, T., Suhara, Y., Takayama, H., and Waku, K. (2000) Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor. J. Biol. Chem. 275, 605-612
13. Sugiura, T., Kondo, S., Kodaka, T., Nakane, S., Yamashita, A., Kishimoto, S., Waku, K., and Ishima, Y. (1998) Biosynthesis and actions of anandamide and 2-arachidonoylglycerol: two endogenous cannabimimetic molecules in Essential Fatty Acids and Eicosanoids (Riemesma, R.A., Armstrong, R., Kelly, W., and Wilson, R., eds.) pp. 380-384, AOCS Press, Champaign
14. Sugiura, T. and Waku, K. (2000) 2-Arachidonoylglycerol and the cannabinoid receptors. Chem. Phys. Lipids 108, 89-106
15. Stella, N., Schweitzer, P., and Piomelli, D. (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773-778
16. Savinainen, J.R., Jarvinen, T., Laine, K., and Laitinen, J.T. (2001) Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. Br. J. Pharmacol. 134, 664-672
17. Ameri, A. and Simmet, T. (2000) Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. Naunyn Schmiedebergs Arch. Pharmacol. 361,265-272
18. Herkenham, M. (1995) Localization of cannabinoid receptors in brain and periphery in Cannabinoid Receptors (Pertwee, R.G., ed.) pp. 145-166, Academic Press, London
19. Galiegue, S., Mary, S., Marchand, J., Dussossoy, D., Carriere, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G., and Casellas, P. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232, 54-61
20. Iwamura, H., Suzuki, H., Ueda, Y., Kaya, T., and Inaba, T. (2001) In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor. J. Pharmacol. Exp. Ther. 296, 420-425
21. Hollister, L.E. (1992) Marijuana and immunity. J. Psychoactive Drugs 24, 159-164
22. Prescott, S.M. and Majerus, P.W. (1983) Characterization of 1, 2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerolintermediate. J. Biol. Chem. 258, 764-769
23. Bisogno, T., Sepe, N., Melck, D., Maurelli, S., De Petrocellis, L., and Di Marzo, V. (1997) Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem. J. 322, 671-677
24. Varga, K., Wagner, J.A., Bridgen, D.T., and Kunos, G. (1998) Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J. 12, 1035-1044
25. Di Marzo, V., Bisogno, T., De Petrocellis, L., Melck, D., Orlando, P., Wagner, J.A., and Kunos, G. (1999) Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem. 264, 258-267
26. Berdyshev, E.V., Schmid, P.C., Krebsbach, R.J., and Schmid, H.H.O. (2001) Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. FASEB J. 15, 2171-2178
27. Sugiura, T., Kodaka, T., Nakane, S., Kishimoto, S., Kondo, S., and Waku, K. (1998) Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? Biochem. Biophys. Res. Commun. 243,838-843
28. Lee, M., Yang, K.H., and Kaminski, N.E. (1995) Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J. Pharmacol. Exp. Ther 275, 529-536
29. Ouyang, Y., Hwang, S.G., Han, S.H., and Kaminski, N.E. (1998) Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. Mol. Pharmacol. 53, 676-683
30. Gallily, R., Breuer, A., and Mechoulam, R. (2000) 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-a production in murine macrophages, and in mice. Eur. J. Pharmacol. 406, R5-7
31. Chang, Y.H., Lee, S.T., and Lin, W.W. (2001) Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids. J. Cell. Biochem. 81, 715-723
32. Carayon, P., Marchand, J., Dussossoy, D., Derocq, J.M., Jbilo, O., Bord, A., Bouaboula, M., Galiegue, S., Mondiere, P., Penarier, G., Le Fur, G., Defrance, T., and Casellas, P. (1998) Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. Blood 92, 3605-3615
33. Jbilo, O., Derocq, J.M., Segui, M., Le Fur, G., and Casellas, P. (1999) Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60. FEBS Lett. 448, 273-277
34. Berdyshev, E.V. (2000) Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids 108, 169-190
35. Cabral, G.A. (2002) Marijuana and cannabinoid effects on immunity and AIDS in Biology of Marijuana (Onaivi, E.S., ed.) pp. 282-307, Taylor & Francis, London
36. Jorda, M.A., Verbakel, S.E., Valk, P.J., Vankan-Berkhoudt, Y.V., Maccarrone, M., Finazzi-Agro, A., Lowenberg, B., and Delwel, R. (2002) Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood 99, 2786-2793
37. Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., Mackie, K., and Stella, N. (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci. 23, 1398-1405
38. 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther 272, 699-707
39. Kobayashi, Y., Arai, S., Waku, K., and Sugiura, T. (2001) Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells. J. Biochem. 129, 665-669
40. Sugiura, T., Kishimoto, S., Oka, S., Gokoh, M., and Waku, K. (2004) Metabolism and physiological significance of anandamide and 2-arachidonoylglycerol, endogenous cannabinoid receptor ligands in Arachidonate Remodeling and Inflammation (Fonteh, A.N. and Wykle, R.L., eds.) pp. 211-237, Birkhauser Verlag, Basel
41. 1 cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol. Pharmacol. 58, 814-820
42. Derkinderen, P., Ledent, C., Parmentier, M., and Girault, J.A. (2001) Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus. J. Neurochem. 77, 957-960
43. Stefano, G.B., Bilfinger, T.V., Rialas, C.M., and Deutsch, D.G. (2000) 2-Arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1. Pharmacol. Res. 42, 317-322
44. Sofia, R.D., Nalepa, S.D., Vassar, H.B., and Knobloch, L.C. (1974) Comparative anti-phlogistic activity of delta 9-tetrahydrocannabinol, hydrocortisone and aspirin in various rat paw edema models. Life Sci. 15, 251-260
45. 9-tetrahydrocannabinol in the rat. Eur. J. Pharmacol. 24, 1-7
46. 9-Tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase. J. Biol. Chem. 271, 9902-9905